REQUEST A DEMO
Total
USD $0.00
Search more companies

Apoteka Jankovic, Novi Sad (Serbia)

Main Activities: Pharmacies and Drug Stores
Full name: Apoteka Jankovic, Novi Sad Profile Updated: April 01, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English Download a sample report

Apoteka Jankovic is a local drug store chain, engaged in the retail distribution of pharmaceuticals and pharmaceutical products. The company is headquartered in the city of Novi Sad.

Headquarters
Milosa Bajica 13
Novi Sad; South Backa;

Contact Details: Purchase the Apoteka Jankovic, Novi Sad report to view the information.

Basic Information
Total Employees:
Purchase the Apoteka Jankovic, Novi Sad report to view the information.
Outstanding Shares:
Purchase the Apoteka Jankovic, Novi Sad report to view the information.
Registered Capital:
Purchase the Apoteka Jankovic, Novi Sad report to view the information.
Financial Auditors:
Purchase the Apoteka Jankovic, Novi Sad report to view the information.
Ratings:
Purchase the Apoteka Jankovic, Novi Sad report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Representative
Ownership Details
Subsidiaries
Company Performance
Financial values in the chart are available after Apoteka Jankovic, Novi Sad report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
15.65%
Total operating revenue
15.65%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
49.4%
Total assets
31.81%
Total equity
32.15%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
2.26%
Return on Equity (ROE)
3.26%
Quick Ratio
0.07%
Cash Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?